Δ133p53α enhances metabolic and cellular fitness of TCR-engineered T cells and promotes superior antitumor immunity - Legscha, Kevin Jan; Ferreira, Edite Antunes; Chamoun, Antonios; Lang, Alexander; Awwad, Mohamed; Ton, Gigi Nu Hoang Quy; Galetzka, Danuta; Guezguez, Borhane; Hundemer, Michael; Bourdon, Jean-Christophe; Munder, Markus; Theobald, Matthias; et al. (Journal for ImmunoTherapy of Cancer, 2021)
Gesehen am 04.11.2021